TrianglePUBLICATIONS · 22018631
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2011 Nov
- First author
- Regan MM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Regan MM
- type
- Author
- name
- Neven P
- type
- Author
- name
- Giobbie-Hurder A
- type
- Author
- name
- Goldhirsch A
- type
- Author
- name
- Ejlertsen B
- type
- Author
- name
- Mauriac L
- type
- Author
- name
- Forbes JF
- type
- Author
- name
- Smith I
- type
- Author
- name
- Láng I
- type
- Author
- name
- Wardley A
- type
- Author
- name
- Rabaglio M
- type
- Author
- name
- Price KN
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Regan MM
- type
- Author
- name
- Neven P
- type
- Author
- name
- Giobbie-Hurder A
- type
- Author
- name
- Goldhirsch A
- type
- Author
- name
- Ejlertsen B
- type
- Author
- name
- Mauriac L
- type
- Author
- name
- Forbes JF
- type
- Author
- name
- Smith I
- type
- Author
- name
- Láng I
- type
- Author
- name
- Wardley A
- type
- Author
- name
- Rabaglio M
- type
- Author
- name
- Price KN
- type
- Author
- bibliography ids
- nci-bib-9f105cb8c30bb671bed5da13
- book metadata
- content sha256
- 46176ea2f2caf6449f2a3696c8ff92a7d4ed60cdec78f55fe227bd16cb8d284f
- document type
- citation
- dois
- 10.1016/S1470-2045(11)70270-4
- electronic publication date
- display
- 2011 Oct 20
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22018631
- immutable id
- pubmed:22018631@46176ea2f2caf6449f2a3696c8ff92a7d4ed60cdec78f55fe227bd16cb8d284f
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 12
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 1101-8
- volume
- 12
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22018631
- provenance
- batch id
- 2529ef2eca926738ab13
- provider
- NCBI PubMed ESummary
- record sha256
- bfa6b0c698230befc27155cc9040e95d48c0eb745ac3c4fb68a0449ed811fac0
- response sha256
- 9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
- retrieved at
- 2026-09-09T23:46:42.856296+00:00
- publication date
- display
- 2011 Nov
- precision
- month
- year
- 2011
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Preserved source evidence · Not medical advice